ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0940

Trans-endothelial Migration of Synovial Fibroblasts Promotes Arthritis Severity Through a PKD1-mediated Feedback Loop

Jaeyeon Kim, Richard Ainsworth and Nunzio Bottini, Cedars-Sinai Medical Center, Los Angeles, CA

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, chemokines, Experimental Arthritis, Fibroblasts, Synovial, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The application of single cell genomic approaches to the study of rheumatoid synovium has recently enabled scientists to study the complex relationship between different cell types and between cells and matrix in RA synovium. This brought new attention to the role of stromal cells in the joint such as fibroblast-like synoviocytes (FLS) and endothelial cells (EC). Recently it has been observed that FLS-like cells -called PRIME cells- are present in the circulation of RA patients suggesting that RA FLS can egress the RA synovium through blood vessels. However, trans-endothelial RA FLS migration has not yet been reported and its mechanisms remain unknown.

Methods: Trans-endothelial migration of FLS was assessed in RA synovium and in synovium of mice with serum transfer induced arthritis (STIA) by in situ hybridization (ISH) and immunofluorescence. Fluorescein-dextran was injected into mice for accessing vascular permeability. A FLS-EC transwell co-culture system in vitro was optimized and bulk RNA sequencing was performed on sorted FLS and EC.

Results: We have collected initial evidence of FLS transmigration through endothelial layers in the synovium of RA patients and mouse STIA (Fig. 1). We next demonstrated that vascular FLS transmigration promotes vascular permeability in vivo. By leveraging a novel in vitro model of human RA FLS endothelial transmigration coupled with bulk RNA sequencing, we show that FLS transmigration not only is able to alter the permeability of EC layers, but also induces chemokines and other proinflammatory genes in EC and metabolic alterations in the EC layer. Trans-endothelial migration also induces expression of polycystin-1 in FLS, encoded by the PKD1 gene. We find that PKD1 serves as a selective promoter of endothelial transmigration of FLS and knockdown of PKD1 in FLS ameliorated arthritis in a mouse model.

Conclusion: Our data suggests the existence of a feedback loop triggered by FLS trans-endothelial migration that tends to perpetuate the process and enhances arthritis severity via induction of local inflammation, EC metabolic abnormalities, and generation of circulating FLS (Fig. 2). Our study contributes to elucidate the role of FLS migration in RA, highlights a novel angle of the FLS-EC interplay in rheumatoid synovium, and helps unravel the origin of PRIME cells in RA.

Supporting image 1

Fig. 1. Trans-END migration of RA FLS. Left: representative microscopy (Hoechst for Nucleus, blue) of RA (N=4) synovium subjected to RNA ISH for PDPN (yellow), FAP (green), and CD31 (red). Scale bar: 100 micron. Right: Representative quantification of ISH intensities through a capillary (≤ 10 micron) wall and lumen from RA synovium. Data were analyzed using Zen (black edition).

Supporting image 2

Fig. 2. Model summary of how trans-endothelial migration of RA FLS contributed to RA pathogenesis. FLS-like cells called PRIME cells are found in circulation in RA patients. Trans-endothelial FLS migration promotes expression of chemokines and and metabolic alterations in EC and induces expression of polycystin_1 (PKD1) in FLS, which further promotes FLS transmigration.


Disclosures: J. Kim: None; R. Ainsworth: None; N. Bottini: Thirona Bio, 2.

To cite this abstract in AMA style:

Kim J, Ainsworth R, Bottini N. Trans-endothelial Migration of Synovial Fibroblasts Promotes Arthritis Severity Through a PKD1-mediated Feedback Loop [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/trans-endothelial-migration-of-synovial-fibroblasts-promotes-arthritis-severity-through-a-pkd1-mediated-feedback-loop/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trans-endothelial-migration-of-synovial-fibroblasts-promotes-arthritis-severity-through-a-pkd1-mediated-feedback-loop/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology